2022
DOI: 10.21577/0103-5053.20210154
|View full text |Cite
|
Sign up to set email alerts
|

Benzophenone Derivatives Showed Dual Anti-Inflammatory and Antiproliferative Activities by Inhibiting COX Enzymes and Promote Cyclin E Downregulation

Abstract: Considering the promising antitumor effects of compounds with dual anti-inflammatory and antiproliferative activities, thus benzophenones analogs (2-7) were evaluated on in vivo antiinflammatory assay and molecular docking analysis. Those with the best molecular docking results were in vitro evaluated on cyclooxygenase (COX) enzymes and tested regarding antiproliferative activity. All derivatives displayed in vivo anti-inflammatory activity. Among them, the substances 2’-hydroxy-4’-benzoylphenyl-β-D-glucopyran… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…1,3,5,6-tetrahydroxyxanthone (3) and guttiferone E (7) were reported as potential inhibitors of NO production and 15-LOX activity ( Dzoyem et al, 2015 ). In the study of Folquitto et al (2022) , some benzophenones analogs including 2′-hydroxy-4′-benzoylphenyl-β-D-glucopyranoside, 4-hydroxy-4′-methoxybenzophenone and 4′-(4″-methoxybenzoyl) phenyl-β-D-glucopyranoside showed interestig values of Glide Score in COX-2 docking evaluation and selectively inhibited COX-2 and COX-1 in an vitro enzymatic assay ( Folquitto et al, 2022 ). Malik et al (2022) showed the ability of some benzophenone derivatives to inhibit pro-inflammatory mediators including IFN-γ, TNF-α, IL-1β, IL-6, GM-CSF, IL-2and nitric oxide (NO) ( Dzoyem et al, 2015 ; Folquitto et al, 2022 ; Malik et al, 2022 ; Saikia et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…1,3,5,6-tetrahydroxyxanthone (3) and guttiferone E (7) were reported as potential inhibitors of NO production and 15-LOX activity ( Dzoyem et al, 2015 ). In the study of Folquitto et al (2022) , some benzophenones analogs including 2′-hydroxy-4′-benzoylphenyl-β-D-glucopyranoside, 4-hydroxy-4′-methoxybenzophenone and 4′-(4″-methoxybenzoyl) phenyl-β-D-glucopyranoside showed interestig values of Glide Score in COX-2 docking evaluation and selectively inhibited COX-2 and COX-1 in an vitro enzymatic assay ( Folquitto et al, 2022 ). Malik et al (2022) showed the ability of some benzophenone derivatives to inhibit pro-inflammatory mediators including IFN-γ, TNF-α, IL-1β, IL-6, GM-CSF, IL-2and nitric oxide (NO) ( Dzoyem et al, 2015 ; Folquitto et al, 2022 ; Malik et al, 2022 ; Saikia et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%
“…In the study of Folquitto et al (2022) , some benzophenones analogs including 2′-hydroxy-4′-benzoylphenyl-β-D-glucopyranoside, 4-hydroxy-4′-methoxybenzophenone and 4′-(4″-methoxybenzoyl) phenyl-β-D-glucopyranoside showed interestig values of Glide Score in COX-2 docking evaluation and selectively inhibited COX-2 and COX-1 in an vitro enzymatic assay ( Folquitto et al, 2022 ). Malik et al (2022) showed the ability of some benzophenone derivatives to inhibit pro-inflammatory mediators including IFN-γ, TNF-α, IL-1β, IL-6, GM-CSF, IL-2and nitric oxide (NO) ( Dzoyem et al, 2015 ; Folquitto et al, 2022 ; Malik et al, 2022 ; Saikia et al, 2023 ). Another study reported the potential of hydroxyxanthone derivatives to inibit COX-2 enzyme ( Dzoyem et al, 2015 ; Folquitto et al, 2022 ; Malik et al, 2022 ; Saikia et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation